Unknown

Dataset Information

0

Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer.

ABSTRACT:

SUBMITTER: Thompson LL 

PROVIDER: S-EPMC8047752 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer.

Thompson Leah L LL   Yoon Jaewon J   Krasnow Nira A NA   Chang Michael S MS   Li Edward B EB   McMahon Devon E DE   Chen Steven T ST  

JAMA dermatology 20210414

Similar Datasets

Unknown Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma.
| S-EPMC7216458 | biostudies-literature
Unknown Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
| S-EPMC10796160 | biostudies-literature
Unknown Corticosteroid-resistant immune-related adverse events: a systematic review.
| S-EPMC10806650 | biostudies-literature
Unknown Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events.
| S-EPMC10674388 | biostudies-literature
Unknown Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
| S-EPMC10283025 | biostudies-literature
Unknown Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit.
| S-EPMC9055047 | biostudies-literature
Unknown Cutaneous Adverse Reactions and Survival Outcomes of Advanced Melanoma Treated with Immune Checkpoint Inhibitors in an Academic Medical Centre in Singapore.
| S-EPMC11311877 | biostudies-literature
Unknown Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children.
| S-EPMC8056312 | biostudies-literature
Unknown Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis.
| S-EPMC8072154 | biostudies-literature
Unknown Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.
| S-EPMC10705211 | biostudies-literature